TY - JOUR
T1 - The contribution of musculoskeletal disorders in multimorbidity
T2 - Implications for practice and policy
AU - Duffield, Stephen J.
AU - Ellis, Benjamin M.
AU - Goodson, Nicola
AU - Walker-Bone, Karen
AU - Conaghan, Philip G.
AU - Margham, Tom
AU - Loftis, Tracey
N1 - Funding Information:
SJD is funded by PhD studentship within the ARUK/MRC centre ( 20665 ) for MSK health and work. BME and TL are employed by Arthritis Research UK. PGC is supported in part by the National Institute for Health Research (NIHR) , Leeds Biomedical Research Centre . The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health.
Publisher Copyright:
© 2017 The Authors
PY - 2017/4
Y1 - 2017/4
N2 - People frequently live for many years with multiple chronic conditions (multimorbidity) that impair health outcomes and are expensive to manage. Multimorbidity has been shown to reduce quality of life and increase mortality. People with multimorbidity also rely more heavily on health and care services and have poorer work outcomes. Musculoskeletal disorders (MSDs) are ubiquitous in multimorbidity because of their high prevalence, shared risk factors, and shared pathogenic processes amongst other long-term conditions. Additionally, these conditions significantly contribute to the total impact of multimorbidity, having been shown to reduce quality of life, increase work disability, and increase treatment burden and healthcare costs. For people living with multimorbidity, MSDs could impair the ability to cope and maintain health and independence, leading to precipitous physical and social decline. Recognition, by health professionals, policymakers, non-profit organisations, and research funders, of the impact of musculoskeletal health in multimorbidity is essential when planning support for people living with multimorbidity.
AB - People frequently live for many years with multiple chronic conditions (multimorbidity) that impair health outcomes and are expensive to manage. Multimorbidity has been shown to reduce quality of life and increase mortality. People with multimorbidity also rely more heavily on health and care services and have poorer work outcomes. Musculoskeletal disorders (MSDs) are ubiquitous in multimorbidity because of their high prevalence, shared risk factors, and shared pathogenic processes amongst other long-term conditions. Additionally, these conditions significantly contribute to the total impact of multimorbidity, having been shown to reduce quality of life, increase work disability, and increase treatment burden and healthcare costs. For people living with multimorbidity, MSDs could impair the ability to cope and maintain health and independence, leading to precipitous physical and social decline. Recognition, by health professionals, policymakers, non-profit organisations, and research funders, of the impact of musculoskeletal health in multimorbidity is essential when planning support for people living with multimorbidity.
KW - Arthritis
KW - Back pain
KW - Co-morbidity
KW - Management
KW - Multimorbidity
KW - Musculoskeletal
KW - Osteoarthritis
KW - Osteoporosis
KW - Policy
KW - Prevalence
UR - http://www.scopus.com/inward/record.url?scp=85032190936&partnerID=8YFLogxK
U2 - 10.1016/j.berh.2017.09.004
DO - 10.1016/j.berh.2017.09.004
M3 - Review Article
C2 - 29224692
AN - SCOPUS:85032190936
SN - 1521-6942
VL - 31
SP - 129
EP - 144
JO - Best Practice & Research: Clinical Rheumatology
JF - Best Practice & Research: Clinical Rheumatology
IS - 2
ER -